Interferons_NNS
induce_VBP
normal_JJ
and_CC
aberrant_JJ
retinoic-acid_NN
receptors_NNS
type_NN
alpha_NN
in_IN
acute_JJ
promyelocytic_JJ
leukemia_NN
cells_NNS
:_:
potentiation_NN
of_IN
the_DT
induction_NN
of_IN
retinoid-dependent_JJ
differentiation_NN
markers_NNS
._.

Treatment_NN
of_IN
the_DT
acute_JJ
promyelocytic_JJ
-LRB-_-LRB-
APL_NN
-RRB-_-RRB-
cell_NN
line_NN
NB4_NN
with_IN
interferon_NN
alpha_NN
-LRB-_-LRB-
IFN_NN
-LRB-_-LRB-
alpha_NN
-RRB-_-RRB-
-RRB-_-RRB-
,_,
as_RB
well_RB
as_IN
IFN_NN
-LRB-_-LRB-
beta_NN
-RRB-_-RRB-
and_CC
gamma_NN
,_,
results_VBZ
in_IN
an_DT
increased_VBN
expression_NN
of_IN
the_DT
transcripts_NNS
coding_VBG
for_IN
retinoic-acid_JJ
receptor_NN
type_NN
alpha_NN
-LRB-_-LRB-
RAR_NN
-LRB-_-LRB-
alpha_NN
-RRB-_-RRB-
-RRB-_-RRB-
and_CC
the_DT
leukemia-specific_JJ
retinoic_JJ
acid_NN
receptor_NN
PML-RAR_NN
._.

Transcriptional_JJ
induction_NN
of_IN
the_DT
RAR_NN
-LRB-_-LRB-
alpha_NN
-RRB-_-RRB-
and_CC
PML-RAR_NN
mRNAs_NNS
is_VBZ
rapid_JJ
and_CC
it_PRP
is_VBZ
parallelled_VBN
by_IN
an_DT
increase_NN
in_IN
the_DT
corresponding_JJ
proteins_NNS
._.

Up-regulation_NN
of_IN
RAR_NN
-LRB-_-LRB-
alpha_NN
-RRB-_-RRB-
and_CC
PML-RAR_NN
gene_NN
expression_NN
by_IN
IFN_NN
-LRB-_-LRB-
alpha_NN
-RRB-_-RRB-
is_VBZ
accompanied_VBN
by_IN
a_DT
strong_JJ
potentiation_NN
in_IN
the_DT
induction_NN
of_IN
2_CD
retinoid-dependent_JJ
granulocytic_JJ
markers_NNS
,_,
i.e._FW
,_,
granulocyte-colony-stimulating_JJ
factor_NN
receptor_NN
mRNA_NN
and_CC
leukocyte_NN
alkaline_NN
phosphatase_NN
._.

However_RB
,_,
IFN_NN
-LRB-_-LRB-
alpha_NN
-RRB-_-RRB-
does_VBZ
not_RB
have_VB
any_DT
effects_NNS
on_IN
the_DT
retinoid-dependent_JJ
regulation_NN
of_IN
the_DT
myeloid_JJ
surface_NN
markers_NNS
CD11b_NN
and_CC
CD33_NN
._.

The_DT
IFN-dependent_JJ
increase_NN
in_IN
RAR_NN
-LRB-_-LRB-
alpha_NN
-RRB-_-RRB-
levels_NNS
and_CC
the_DT
enhancing_JJ
effect_NN
of_IN
the_DT
cytokine_NN
on_IN
retinoid-dependent_JJ
granulocytic_JJ
markers_NNS
expression_NN
may_MD
be_VB
a_DT
characteristic_NN
of_IN
PML-RAR_NN
positive_JJ
cells_NNS
,_,
since_IN
the_DT
phenomena_NNS
are_VBP
not_RB
observed_VBN
in_IN
HL-60_NN
promyelocytes_NNS
._.

Interferons_NNS
as_RB
well_RB
as_IN
retinoids_NNS
inhibit_VBP
the_DT
growth_NN
of_IN
NB4_NN
cells_NNS
,_,
although_IN
the_DT
2_CD
classes_NNS
of_IN
compounds_NNS
do_VBP
not_RB
significantly_RB
interact_VB
in_IN
terms_NNS
of_IN
anti-proliferative_JJ
activity_NN
._.

These_DT
results_NNS
suggest_VBP
the_DT
possible_JJ
use_NN
of_IN
combinations_NNS
between_IN
IFNs_NNS
and_CC
retinoic_JJ
acid_NN
in_IN
the_DT
cyto-differentiating_JJ
treatment_NN
of_IN
APL_NN
patients_NNS
._.

